PRJNA863067
Peritoneal dialysis Microbiome and Metabolome
Incorporating monitoring of the gut microecosystem into the long-term management of PD therapy will be a new strategy, and the application of probiotics and SCFAs to improve the PD gut microbiota to reduce the risk of enterogenic peritonitis and cardiovascular events will be a new intervention.